
Insecticides (India) Reports Q1 FY27 Results: Revenue Declines 12% Amidst Rainfall Deficit, Gross Margin Expands
Insecticides (India) Limited (IIL), a major fully integrated crop protection and nutrition company in India, has released its unaudited financial results for the first quarter of Fiscal Year 2027 (Q1 FY27). The results reflect challenges due to rainfall deficit across the country.The consolidated financials show a decline in revenue from operations but highlighted improvements in gross profit margins.
| Particulars (Rs. Crs) | Q1 FY27 | Q1 FY26 | Y-o-Y | FY26 |
|---|---|---|---|---|
| Revenue from Operations | 612 | 691 | -12% | 2,140 |
| Gross Profit | 193 | 202 | -4% | 675 |
| Gross Profit Margin (%) | 31.6% | 29.2% | 31.5% | |
| EBITDA | 68 | 85 | -20% | 227 |
| EBITDA Margin (%) | 11.1% | 12.2% | 10.6% | |
| Profit After Tax | 44 | 58 | -24% | 139 |
Key Operational Highlights and Strategic Focus
Despite the revenue contraction, IIL reported that its gross profit margins expanded by 240 basis points (bps) year-on-year due to disciplined pricing actions.The company utilized Q1 FY27 for significant product launches and expanding strategic partnerships. A major highlight was the pan-India launch of GRANUVIA, a next-generation insecticide introduced through collaboration with Corteva Agriscience. Spinoace was also introduced during the quarter as part of this partnership. KAEROS continued its growth trajectory, strengthening its market position through portfolio expansion and distribution footprint reinforcement.
In terms of farmer engagement, IIL reported high-impact outreach activities in Q1 FY27, including 3,600+ farmer meetings, 14,000+ farmers visits, 600+ filed days, and 1,400+ demonstrations across various crops.
Building on this farmer acceptance, the company plans to double the number of IIL Crop Solutions (ICS plots) from the current 36. These plots cover four major crops—rice, cotton, chilli, and soybean—across 14 states.
Management Commentary
Commenting on the performance, Mr. Rajesh Kumar Aggarwal, MD of Insecticides (India) Ltd., stated that the company delivered a resilient performance despite subdued demand. He attributed this resilience to a diversified product portfolio, strong execution capabilities, and clear strategic direction. While deficient rainfall impacted near-term revenue, pricing discipline and operating efficiencies helped maintain stability in gross margin.Mr. Aggarwal added that the company is confident about building momentum through the coming quarters, supported by sustained investments in manufacturing, research, digital transformation, premiumization, and global partnerships. He noted that collaborations with global innovators are strengthening margins and enhancing growth quality. Furthermore, he highlighted KAEROS as evolving into a significant growth platform, along with advancing the international business footprint.
Company Overview
Insecticides (India) Ltd. is recognized as one of India's leading fully integrated crop protection and nutrition companies. The company offers farmers a wide range of products for crop protection needs, boasting a portfolio that includes 20+ technical products and over 130 formulation products. IIL also owns the 'Tractor Brand,' which enjoys popularity within the farming community.IIL benefits from competitive advantages derived from backward integration, operating technical synthesis plants at Chopanki and Dahej. The company has state-of-the-art manufacturing facilities in Choapanki (Rajasthan), Samba and Udhampur (Jammu & Kashmir), Dahej (Gujarat), with a future facility planned for Sotanala (Rajasthan).
The company maintains a substantial reach across India, serving over 7,500,000 farmers, 70,000+ dealers, and 8,500+ distributors.
INSECTICID Stock Price Movement
Insecticides (India) Limited shed 1.51% in trading today, settling at a post-market indicative close of ₹634. The stock saw significant intraday movement, trading within a range that extended from a low of ₹603.35 to a high of ₹655.65.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.